Butzke B, Oduncu FS, Severin F, Pfeufer A, Heinemann V, Giessen-Jung C, et al. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance. AO [Internet]. 2016 Mar. 3 [cited 2024 Sep. 5];55(3):318-2. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25231